CD4+ T cell mediated intestinal immunity: Chronic inflammation versus immune regulation

Gut

Volumn 54, Issue 1, 2005, Pages 60-69

  Westendorf, A M ^a   Templin, M ^a   Geffers, R ^a   Deppenmeier, S ^b   Gruber, A D ^b   Probst Kepper, M ^c   Hansen, W ^a   Liblau, R S ^d   Gunzer, F ^c   Bruder, D ^a   Buer, J ^a,c  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; GAMMA INTERFERON; HEMAGGLUTININ; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; PROTEIN NRP 1; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENTERITIS; GENE DELETION; GENE EXPRESSION; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLUENZA VIRUS A; INTESTINE CELL; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; ENTEROCYTES; GENE EXPRESSION PROFILING; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC;

EID: 19944416542     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.037663     Document Type: Article

References (49)

1. Nagler-Anderson C. Man the barrier! Strategic defences in the intestinal mucosa. Nat Rev Immunol 2001;1:59-67.
2. Kisielow P, Teh HS, Bluthmann H, et al. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 1988;335:730-3.
3. Von Boehmer H, Aifantis I, Gounari F, et al. Thymic selection revisited: how essential is it? Immunol Rev 2003;191:62-78.
4. Melamed D, Friedman A. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 1993;23:935-42.
5. Monteleone I, Vavassori P, Biancone L, et al, Immunoregulation in the gut: success and failures in human disease. Gut 2002;50(suppl 3):III60-4.
6. Sakaguchi S. Regulatory T cells: mediating compromises between host and parasite. Naf Immunol 2003;4:10-1.
7. Powrie F, Correa-Oliveira R, Mauze S, et al. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994;179:589-600.
8. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2:816-22.
9. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-7.
10. Dohi T, Fujihashi K, Koga T, et al. T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice. Gastroenterology 2003;124:672-82.
11. Caton AJ, Stark SE, Shih FF, et al. Transgenic mice that express different forms of the influenza virus hemagglutinin as a neo-self-antigen. J Clin Immunol 1995;15(supp16):106-12S.
12. Pinto D, Robine S, Jaisser F, et al. Regulatory sequences of the mouse villin gene that etficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines. J Biol Chem 1999;274:6476-82.
13. Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981;289:366-73.
14. Kirberg J, Baron A, Jakob S, et al. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med 1994;180:25-34.
15. Guy-Grand D, Griscelli C, Vassalli P. The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions. J Exp Med 1978;148:1661-77.
16. Rogler G, Daig R, Aschenbrenner E, et al. Establishment of long-term primary cultures of human small and large intestinal epithelial cells. Lab Invest 1998;78:889-90.
17. Hackett CJ, Dietzschold B, Gerhard W, et al. Influenza virus site recognized by a murine helper T cell specific for H1 strains. Localization to a nine amino acid sequence in the hemagglutinin molecule. J Exp Med 1983;158:294-302.
18. Bruder D, Probst-Kepper M, Westendorf AM, et al. Frontline: Neuropilin-1: a surface marker of regulatory T cells, Eur J Immunol 2004;34:623-30.
19. Buer J, Lanoue A, Franzke A, et al. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med 1998;187:177-83.
20. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
21. Elewaut D, De Keyser F, Cuvelier C, et al. Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis. Scand J Gastroenterol 1998;33:743-8.
22. Croft M. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev 2003;14:265-73.
23. Raedler A, Fraenkel S, Klose G, et al. Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors. Clin Exp Immunol 1985;60:518-24.
24. Hornquist CE, Lu X, Rogers-Fani PM, et al. G(alpha)i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. J Immunol 1997;158:1068-77.
25. Podolsky DK, Lobb R, King N, et al. Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody. J Clin Invest 1993;92:372-80.
26. Sun FF, Lai PS, Yue G, et al. Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation 2001;25:33-45.
27. Wang L, Walia B, Evans J, et al. IL-6 induces NF-kappaB activation in the intestinal epithelia. J Immunol 2003;171:3194-201.
28. De Maria R, Boirivant M, Cifone MG, et al. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J Clin Invest 1996;97:316-22.
29. Campbell JJ, Murphy KE, Kunkel FJ, et al. CCR7 expression and memory T cell diversity in humans. J Immunol 2001;166:877-84.
30. Kabashima K, Saji T, Murata T, et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 2002;109:883-93.
31. Often K, Dragoo J, Wang HC, et al. Antigen-induced chemokine activation in mouse buccal epithelium. Biochem Biophys Res Commun 2003;304:36-40.
32. Te Velde AA, van Kooyk Y, Braat H, et al. Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur J Immunol 2003;33:143-51.
33. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
34. Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000;289:1352-5.
35. Shimizu J, Yamazaki S, Takahashi T, et al. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3:135-42.
36. O'Garra A, Vieira P. Twenty-first century Foxp3. Nat Immunol 2003;4:304-6.
37. Degermann S, Reilly C, Scott B, et al. On the various manifestations of spontaneous autoimmune diabetes in rodent models. Eur J Immunol 1994;24:3155-60.
38. Sarukhan A, Lanoue A, Franzke A, et al. Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model. EMBO J 1998;17:71-80.
39. Lanoue A, Bona C, Von Boehmer H, et al. Conditions that induce tolerance in mature CD4+ T cells. J Exp Med 1997;185:405-14.
40. Comet A, Savidge TC, Cabarrocas J, et al. Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? Proc Natl Acad Sci USA 2001;98:13306-11.
41. Boirivant M, Marini M, Di Felice G, et al. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show detective CD2 pathway-induced apoptosis. Gastroenterology 1999;116:557-65.
42. Targan SR, Deem RL, Liu M, et al. Detinition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J Immunol 1995;154:664-75.
43. Elson CO, Holland SP, Dertzbaugh MT, et al. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J Immunol 1995;154:1032-40.
44. Miller A, Lider O, Roberts AB, et al. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A 1992;89:421-5.
45. Mowat AM, Lamont AG, Strobel S, et al. The role of antigen processing and suppressor T cells in immune responses to dietary proteins in mice. Adv Exp Med Biol 1987;216A:709-20.
46. Roncarolo MG, Levings MK. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 2000;12:676-83.
47. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000;101:455-8.
48. Ludviksson BR, Seegers D, Resnick AS, et al. The etfect of TGF-beta1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells. Eur J Immunol 2000;30:2101-11.
49. Strober W, Kelsall B, Marth T. Oral tolerance. J Clin Immunol 1998;18:1-30.